BC Extra | Jun 11, 2018
Preclinical News

Summit identifies two new classes of antibiotics

Summit Therapeutics plc (LSE:SUMM; NASDAQ:SMMT) identified two new types of narrow-spectrum antibiotics targeting new Neisseria gonorrhoeae targets that could help treat gonorrhea. Summit presented its findings at the American Society for Microbiology Microbe (ASM Microbe)...
Items per page:
1 - 1 of 1